ArticleResearch (Washington, D.C.)2025
An Explainable Two-Stage Machine Learning Model for Predicting the Post-Thrombolysis Complications in Stroke Patients: A Multi-Center Study.
Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current tools for predicting the thrombolysis risk in patients after stroke exhibit limited event prediction in early post-thrombolysis hemorrhagic events. This highlights an unmet medical need to improve the tools for stroke management. We developed an explainable 2-stage machine learning model for stroke risk stratification to predict the risk of bleeding, composite complications, and all-cause death in patients before and after thrombolysis therapy. The model integrated LightGBM, XGBoost, random forest model (RF), decision tree model (DT), and logistic regression model (LR), and was trained on data from 5,333 patients from Tongji Hospital, achieving improved predictive accuracy in the post-thrombolysis stage compared to the pre-thrombolysis stage. The model exhibited increased area under the curve (AUC) of 0.7581 [95% confidence interval (CI), 0.6955 to 0.8177] and 0.7234 (0.6527 to 0.7909) (bleeding), 0.7625 (0.7324 to 0.7936) and 0.7035 (0.6685 to 0.7392) (composite complications), and 0.9264 (0.8736 to 0.9660) and 0.845 (0.7454 to 0.9375) (death) in post-thrombolysis stage than in pre-thrombolysis stage. External validation using data of 526 patients across 2 different hospitals confirmed the robustness of the model. Key predictors such as temperature, vital signs, and demographic factors were identified. A prototype embedding the best-performing model was constructed. This model enhances thrombolysis risk prediction and supports personalized patient care management, demonstrating its potential for clinical decision support system integration into stroke management strategies.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.